Kai Lin Xu; Jun Nian Zheng
4 clinical trials · Sponsor
◉ Watch Kai Lin Xu; Jun Nian Zheng
| Record | Firm | Date |
|---|---|---|
| Clinical Study of CAR-iNKT Cells in the Treatment of Relapsed/Refractory/High-risk B-cell Tumors (NCT04814004) | Kai Lin Xu; Jun Nian Zheng | 2021-03-19 |
| CTA101 UCAR-T Cell Injection for Treatment of Relapsed or Refractory CD19+ B-cell Acute Lymphoblastic Leukemia (NCT04154709) | Kai Lin Xu; Jun Nian Zheng | 2019-12-10 |
| CD22 Targeting CAR-T Therapy Against B Cell Hematological Malignancies (NCT02794961) | Kai Lin Xu; Jun Nian Zheng | 2016-06-01 |
| Humanized CAR-T Therapy for Treatment of B Cell Malignancy (NCT02782351) | Kai Lin Xu; Jun Nian Zheng | 2016-05-01 |
Track Kai Lin Xu; Jun Nian Zheng automatically
Every clearance here is in the API, with alerts when new ones post.